Dendreon Corporation (NASDAQ: DNDN) needs all the goods news it can get. While the American Society for Clinical Oncology (ASCO) has its annual meeting in les than two weeks and ... Read Full Story »
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) ... Read Full Story »
Dendreon Corporation (NASDAQ: DNDN) is in trouble. That is what the performance is telling investors. The maker of Provenge as a late-stage prostate cancer treatment has three issues working against ... Read Full Story »
KYTHERA Biopharmaceuticals, Inc. has just joined in with the companies which have filed to come public via an initial public offering. The common stock plans to be listed on The ... Read Full Story »
Rosetta Genomics, Ltd. (NASDAQ: ROSG) was an exponential winner on Wednesday due to getting a Medicare reimbursement ruling in its favor. The company had announced that the Medicare Administrative Contractor ... Read Full Story »
Rosetta Genomics Ltd. (NASDAQ: ROSG) is not often in the news, but it is in the news a big way now. The microRNA-based molecular diagnostic test maker has announced that Novitas, ... Read Full Story »
Index changes are generally speaking a fairly routine event. They can also create underlying moves in the companies added and deleted from them as money management firms often buy and ... Read Full Story »
Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial of a biotech stock as there can be. It often traded huge volume around drug approval or study news, and shares ... Read Full Story »
It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. ... Read Full Story »
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance of really setting the trend for the entire biotech ... Read Full Story »
Dendreon Corporation (NASDAQ: DNDN) has reported its quarterly results and the reaction is a bit cool. This is growth of almost 200%, as net product revenue for the quarter was ... Read Full Story »
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is trading up so much higher that you might think the company is being acquired. The real reason for the huge share gains is based ... Read Full Story »
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) already had problems before a fund called Tang Capital accused it of being insolvent this week. Over the last year this stock has fallen down ... Read Full Story »
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the biggest public merger rumors out there. At least that is the belief ... Read Full Story »
Amylin Pharmaceuticals, Inc. (AMLN) is supposed to be getting a takeover offer soon, or at least it is expected to receive or disclose several possible bids soon. Now the company ... Read Full Story »